BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21497289)

  • 1. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.
    Cicek MS; Lindor NM; Gallinger S; Bapat B; Hopper JL; Jenkins MA; Young J; Buchanan D; Walsh MD; Le Marchand L; Burnett T; Newcomb PA; Grady WM; Haile RW; Casey G; Plummer SJ; Krumroy LA; Baron JA; Thibodeau SN
    J Mol Diagn; 2011 May; 13(3):271-81. PubMed ID: 21497289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive duplex MSI test and BAT40 germline polymorphism.
    Kang SY; Kim KM
    APMIS; 2021 Oct; 129(10):607-615. PubMed ID: 34342050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.
    Esemuede I; Forslund A; Khan SA; Qin LX; Gimbel MI; Nash GM; Zeng Z; Rosenberg S; Shia J; Barany F; Paty PB
    Ann Surg Oncol; 2010 Dec; 17(12):3370-8. PubMed ID: 20703819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
    Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
    Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability in young patients with mucinous colorectal cancers - characterization using molecular testing, immunohistochemistry, and histological features.
    Mathews NS; Masih D; Mittal R; Perakath B; Sakthi D; Rebekah G; Pai R; Pulimood AB
    Indian J Cancer; 2019; 56(4):309-314. PubMed ID: 31607698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
    Boland CR; Thibodeau SN; Hamilton SR; Sidransky D; Eshleman JR; Burt RW; Meltzer SJ; Rodriguez-Bigas MA; Fodde R; Ranzani GN; Srivastava S
    Cancer Res; 1998 Nov; 58(22):5248-57. PubMed ID: 9823339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
    Jang M; Kwon Y; Kim H; Kim H; Min BS; Park Y; Kim TI; Hong SP; Kim WK
    BMC Cancer; 2018 Dec; 18(1):1218. PubMed ID: 30514259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a fluorescent multiplex assay for detection of MSI-High tumors.
    Bacher JW; Flanagan LA; Smalley RL; Nassif NA; Burgart LJ; Halberg RB; Megid WM; Thibodeau SN
    Dis Markers; 2004; 20(4-5):237-50. PubMed ID: 15528789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of performance of 6-mononucleotide site panel and NCI panel for microsatellite instability detection in patients with colorectal adenocarcinoma.
    He L; Yang J; Zhang B; Wang Y; Wang J; Ye Q
    Pathol Res Pract; 2023 Apr; 244():154390. PubMed ID: 36905693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
    Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
    Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer.
    Morandi L; de Biase D; Visani M; Monzoni A; Tosi A; Brulatti M; Turchetti D; Baccarini P; Tallini G; Pession A
    Int J Colorectal Dis; 2012 May; 27(5):647-56. PubMed ID: 22108904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Three Customized MSI Panels to Improve the Detection of Microsatellite Instability in Gastric Cancer.
    Park J; Shin S; Yoo HM; Lee SW; Kim JG
    Clin Lab; 2017 Apr; 63(4):705-716. PubMed ID: 28397474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and polymorphism of Bethesda panel markers in Chinese population.
    Zheng Y; Chen J; Zhang X; Xie L; Zhang Y; Sun Y
    Bull Cancer; 2020 Nov; 107(11):1091-1097. PubMed ID: 32980144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
    Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
    Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
    Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
    Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.